Case number 1:20-cv-00199
Allergan Sales, LLC et al v. Breckenridge Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 18, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per DI# [13]. (cna, ) |
| Oct 20, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:14-cv-01119-MSG. These actions are consolidated for all purposes and ALL FUTURE FILINGS SHALL BE MADE IN CIV. NO. 14-1119-MSG. (nmg) |
| Oct 20, 2020 | 12 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER regarding consolidation of C.A. 1:20-cv-00199-MSG with the previously consolidated Action No. C.A. No. 14-1119-MSG. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG, 1:14-cv-01504-MSG-SRF, 1:20-cv-00199-MSG(nmg) |
| Oct 20, 2020 | 13 | Judgment (7) Docket Text: FINAL JUDGMENT. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG et al.(nmg) |
| Oct 16, 2020 | 10 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Consolidate Cases by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy) |
| Oct 16, 2020 | 11 | Proposed Order (7) Docket Text: PROPOSED ORDER -- Agreed Upon Final Judgment by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy) |
| May 18, 2020 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc. filed by Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc.. (Blumenfeld, Jack) |
| Apr 24, 2020 | 8 | Answer to Complaint (8) Docket Text: ANSWER to [1] Complaint, and Affirmative and Other Defenses by Breckenridge Pharmaceutical, Inc..(Brauerman, Stephen) |
| Feb 27, 2020 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Allergan Sales, LLC, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.: For Breckenridge Pharmaceutical, Inc. waiver sent on 2/26/2020, answer due 4/27/2020. (Tigan, Jeremy) |
| Feb 12, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Mitchell S. Goldberg of the U.S. District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) |
| Feb 11, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 2/11/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr) |
| Feb 11, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan Sales, LLC, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.. Breckenridge Pharmaceutical, Inc. served on 2/11/2020, answer due 3/3/2020. (Tigan, Jeremy) |
| Feb 10, 2020 | 1 | Exhibit A-B (9) |
| Feb 10, 2020 | 1 | Civil Cover Sheet (1) |
| Feb 10, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Feb 10, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 30, 2019. Date of Expiration of Patent: June 9, 2020.Thirty Month Stay Deadline: 12/10/2020. (myr) |
| Feb 10, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,763,476. (myr) |
| Feb 10, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc. filed by Allergan Pharmaceuticals International Limited, Allergan Sales, LLC, Allergan USA, Inc. (myr) |
| Feb 10, 2020 | 1 | Complaint* (1) |
